The “more is better” intuition runs deep. If a multivitamin helps, a megadose helps more. If ibuprofen kills a headache, more ibuprofen kills it faster. If caffeine sharpens focus, double the dose doubles the focus. Pharmacology and toxicology have spent a century demonstrating that this intuition is wrong, often dangerously wrong. Most beneficial substances follow a dose-response curve that flattens, peaks, and then turns harmful. Understanding where the curve bends matters more than understanding what the substance does.
The dose-response curve is real
Almost every substance that has any biological effect, whether a nutrient, drug, or supplement, follows some version of a U-shaped or inverted-U dose-response relationship. Too little produces deficiency. The middle range produces benefit. Too much produces toxicity, which often looks identical to deficiency. Vitamin D is the textbook example. Below 20 ng/mL is deficient. 30 to 50 is likely beneficial. Above 100 produces hypercalcemia, kidney stones, and cardiovascular risk. The same logic applies to iron, selenium, zinc, vitamin A, and most fat-soluble nutrients. The supplement industry’s marketing implies the curve only goes up. The biochemistry says the curve has a turnaround that gets ignored, and the turnaround is where the emergency room visits live.
Common offenders most people miss
Acetaminophen is the most common cause of acute liver failure in the United States, almost entirely from overdoses that often happen accidentally when people take it alongside cold medicines that already contain it. NSAIDs like ibuprofen at chronic high doses cause gastric bleeding, kidney damage, and elevated cardiovascular risk. High-dose vitamin B6 produces peripheral neuropathy that can be permanent. High-dose vitamin E increases mortality in some meta-analyses. Caffeine above 400 mg in a session impairs the focus it was supposed to enhance and can trigger arrhythmias in susceptible people. Iron supplementation in people without deficiency raises oxidative stress and can mask underlying conditions. None of these are exotic substances. They are sitting in most American medicine cabinets, dosed casually.
Why the wrong intuition persists
Several things keep the more-is-better belief alive. Marketing emphasizes potency because it differentiates products on the shelf. Stories of miraculous recoveries with high-dose interventions get repeated, while stories of slow toxicity do not, because toxicity is harder to attribute. Many beneficial effects are nonlinear: small doses can produce most of the benefit, while bigger doses produce mostly side effects with little additional gain. And the body’s compensatory systems can absorb a lot before symptoms appear, which gives users false confidence. By the time damage shows up on labs, the person has been taking the dose for years. The early warning signs are usually in measurable biomarkers, not subjective feeling.
The takeaway
Treat dose like a real variable, not an optional one. For prescription drugs, follow the dosing schedule and ask before stacking products with overlapping ingredients. For supplements, look up the upper tolerable intake, not just the recommended daily allowance, and stop when you hit it. For caffeine and other stimulants, more is often less. The shape of the dose-response curve is not optional advice. It is biochemistry, and it bends the same way for everyone.
Leave a Reply